NextCure short interest was 32.54% of the float on July 15th, according to new data we received from Benzinga. Short interest totaled 1,323,834 shares, which was an increase of 734.74% from June 30th.
It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.
NextCure Hedge Fund Activity
We have seen 9 institutional investors add shares of NextCure stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OPALEYE MANAGEMENT INC. added 141,181 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,507,813
- EXOME ASSET MANAGEMENT LLC removed 49,500 shares (-30.0%) from their portfolio in Q1 2026, for an estimated $528,660
- VERDAD ADVISERS, LP added 42,955 shares (+inf%) to their portfolio in Q1 2026, for an estimated $458,759
- SQUADRON CAPITAL MANAGEMENT LLC added 28,034 shares (+11.8%) to their portfolio in Q1 2026, for an estimated $299,403
- WOODLINE PARTNERS LP added 27,498 shares (+inf%) to their portfolio in Q1 2026, for an estimated $293,678
- RENAISSANCE TECHNOLOGIES LLC added 26,900 shares (+80.0%) to their portfolio in Q1 2026, for an estimated $287,292
- CITADEL ADVISORS LLC added 15,292 shares (+inf%) to their portfolio in Q1 2026, for an estimated $163,318
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
NextCure Insider Trading Activity
NextCure insiders have traded $NXTC stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NXTC stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC ADAR1 has made 4 purchases buying 17,608 shares for an estimated $87,712 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
